These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23441870)

  • 21. Dysarthria and aphagia: a case study of neuromuscular treatment.
    Harris B; Murry T
    Arch Phys Med Rehabil; 1984 Jul; 65(7):408-12. PubMed ID: 6743001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DAF as instrumental treatment for dysarthria in progressive supranuclear palsy: a case report.
    Hanson WR; Metter EJ
    J Speech Hear Disord; 1980 May; 45(2):268-76. PubMed ID: 6449631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Auditory vs visual speech timing cues as external rate control to enhance verbal intelligibility in mixed spastic-ataxic dysarthric speakers: a pilot study.
    Pilon MA; McIntosh KW; Thaut MH
    Brain Inj; 1998 Sep; 12(9):793-803. PubMed ID: 9755370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automatic speech recognition and training for severely dysarthric users of assistive technology: the STARDUST project.
    Parker M; Cunningham S; Enderby P; Hawley M; Green P
    Clin Linguist Phon; 2006; 20(2-3):149-56. PubMed ID: 16428231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speech recognition and dysarthria: a single subject study of two individuals with profound impairment of speech and motor control.
    Havstam C; Buchholz M; Hartelius L
    Logoped Phoniatr Vocol; 2003; 28(2):81-90. PubMed ID: 14582831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternate motion rates of the speech articulators in adults with cerebral palsy.
    Schliesser HF
    Folia Phoniatr (Basel); 1982; 34(5):258-64. PubMed ID: 7173760
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of listeners' working memory and noise on speech intelligibility in dysarthria.
    Lee Y; Sung JE; Sim H
    Clin Linguist Phon; 2014 Oct; 28(10):785-95. PubMed ID: 24712561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electropalatography in the description and treatment of speech disorders in five children with cerebral palsy.
    Nordberg A; Carlsson G; Lohmander A
    Clin Linguist Phon; 2011 Oct; 25(10):831-52. PubMed ID: 21591933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of articulatory impairment in a child with spastic dysarthria associated with cerebral palsy.
    Marchant J; McAuliffe MJ; Huckabee ML
    Dev Neurorehabil; 2008; 11(1):81-90. PubMed ID: 17943504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effects of intensive voice treatment (LSVT LOUD
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysarthria in Adults With Cerebral Palsy: Clinical Presentation and Impacts on Communication.
    Schölderle T; Staiger A; Lampe R; Strecker K; Ziegler W
    J Speech Lang Hear Res; 2016 Apr; 59(2):216-29. PubMed ID: 27057824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Speech, communication and use of augmentative communication in young people with cerebral palsy: the SH&PE population study.
    Cockerill H; Elbourne D; Allen E; Scrutton D; Will E; McNee A; Fairhurst C; Baird G
    Child Care Health Dev; 2014 Mar; 40(2):149-57. PubMed ID: 23656274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expiratory muscle strength training: speech production outcomes in patients with multiple sclerosis.
    Chiara T; Martin D; Sapienza C
    Neurorehabil Neural Repair; 2007; 21(3):239-49. PubMed ID: 17351085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysarthria of Spinal Cord Injury and Its Management.
    Britton D; Hoit JD; Benditt JO
    Semin Speech Lang; 2017 Jul; 38(3):161-172. PubMed ID: 28618439
    [No Abstract]   [Full Text] [Related]  

  • 35. An evaluation of the effectiveness of PROMPT therapy in improving speech production accuracy in six children with cerebral palsy.
    Ward R; Leitão S; Strauss G
    Int J Speech Lang Pathol; 2014 Aug; 16(4):355-71. PubMed ID: 24521506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of interutterance stability: application to dysarthria.
    Cummins F; Lowit A; van Brenk F
    J Speech Lang Hear Res; 2014 Feb; 57(1):81-9. PubMed ID: 24687469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Listener attitudes toward individuals with cerebral palsy who use speech supplementation strategies.
    Hustad KC; Gearhart KJ
    Am J Speech Lang Pathol; 2004 May; 13(2):168-81. PubMed ID: 15198635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Speech rehabilitation in dysarthria after stroke: a systematic review of the studies.
    Chiaramonte R; Pavone P; Vecchio M
    Eur J Phys Rehabil Med; 2020 Oct; 56(5):547-562. PubMed ID: 32434313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproducibility and variability of speech muscle activity in athetoid dysarthria of cerebral palsy.
    Neilson PD; O'Dwyer NJ
    J Speech Hear Res; 1984 Dec; 27(4):502-17. PubMed ID: 6521456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability and Diagnostic Accuracy of Speech Intelligibility Scores in Children.
    Hustad KC; Oakes A; Allison K
    J Speech Lang Hear Res; 2015 Dec; 58(6):1695-707. PubMed ID: 26381119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.